or Try an Advanced Search...

    Glucose Meter Stocks List

    Symbol Grade Name % Change
    SNY C Sanofi -1.85
    TNDM D Tandem Diabetes Care, Inc. 0.24
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology

    Related ETFs - A few ETFs which own one or more of the above listed Glucose Meter stocks.

    Symbol Grade Name Weight
    PPH D Market Vectors Pharmaceutical ETF 5.12
    VIRS A Pacer BioThreat Strategy ETF 4.88
    PINK D Simplify Health Care ETF 4.75
    EDOC A Global X Telemedicine & Digital Health ETF 3.95
    PID B PowerShares Intl Dividend Achievers 2.8
    View all Glucose Meter ETFs...
    Compare ETFs
    Compare PINK to PID Compare PPH to PID Compare VIRS to EDOC

        Glucose Meter Stocks Recent News

        Date Stock Title
        Oct 2 TNDM Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
        Oct 2 TNDM Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
        Oct 2 TNDM This pharma stock offers an attractive risk-reward says RBC
        Oct 1 TNDM BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch
        Oct 1 TNDM Why Tandem Diabetes Care Stock Took It on the Chin Tuesday
        Oct 1 SNY Update: Market Chatter: Sanofi Asks Bidders to Revise Offers for Consumer Health Unit
        Oct 1 SNY Market Chatter: Sanofi Asks Bidders to Revise Offers for Consumer Health Unit
        Oct 1 TNDM t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock
        Oct 1 SNY Sanofi Is Said to Ask Bidders to Revise Consumer Health Offers
        Sep 30 SNY Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
        Sep 28 SNY Regeneron, Sanofi announce Dupixent approval in China for patients with COPD
        Sep 27 SNY Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
        Sep 27 SNY Regeneron/ Sanofi granted FDA label expansion for Dupixent in COPD
        Sep 27 SNY Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
        Sep 27 SNY Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
        Sep 27 SNY Sanofi, Regeneron get additional Chinese approval for Dupixent
        Sep 27 SNY Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
        Sep 27 SNY Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
        Sep 27 SNY Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD
        Sep 27 SNY Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology
        Glucose Meter

        A glucose meter is a medical device for measuring the amount of glucose in the blood. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking the skin with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in mg/dl or mmol/l.

        Browse All Tags